Luis Ley
Overview
Explore the profile of Luis Ley including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
62
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Christensen R, Yi M, Kang B, Ibrahim S, Anvery N, Dirr M, et al.
J Clin Epidemiol
. 2024 Oct;
175:111514.
PMID: 39353833
No abstract available.
2.
Vaz-Salgado M, Villamayor M, Albarran V, Alia V, Sotoca P, Chamorro J, et al.
Cancers (Basel)
. 2023 Sep;
15(17).
PMID: 37686553
Glioblastoma is a disease with a poor prognosis. Multiple efforts have been made to improve the long-term outcome, but the 5-year survival rate is still 5-10%. Recurrence of the disease...
3.
Christensen R, Yi M, Kang B, Ibrahim S, Anvery N, Dirr M, et al.
J Clin Epidemiol
. 2023 Apr;
158:84-91.
PMID: 37019344
Objectives: Clinical practice guidelines (CPGs) are often created through collaboration among organizations. The use of inconsistent terminology may cause poor communication and delays. This study aimed to develop a glossary...
4.
Salgado M, Earl J, Berrocal V, Arrieta F, Gomez A, Sepulveda-Sanchez J, et al.
Future Sci OA
. 2022 Jun;
8(5):FSO796.
PMID: 35662744
Aim: Glioblastoma (GB) is an aggressive tumor type and the detection of circulating endothelial cells (CECs) in peripheral blood has been related to angiogenesis. Materials & Methods: A prospective single-center...
5.
Vivas D, Roldan I, Ferrandis R, Marin F, Roldan V, Tello-Montoliu A, et al.
Rev Esp Cardiol (Engl Ed)
. 2018 Jun;
71(7):553-564.
PMID: 29887180
During the last few years, the number of patients receiving anticoagulant and antiplatelet therapy has increased worldwide. Since this is a chronic treatment, patients receiving it can be expected to...
6.
Regidor I, Benita V, Del Alamo de Pedro M, Ley L, Castrillo J
Clin Neuropharmacol
. 2017 Apr;
40(3):103-107.
PMID: 28452905
Objectives: This study assesses the effect of levodopa/carbidopa intestinal infusion gel (LCIIG) as an additional treatment in patients with advanced idiopathic Parkinson disease (PD) previously treated with deep brain stimulation...
7.
Rebolleda G, Diez-Alvarez L, Arrondo E, Ley L, Martinez-San Millan J, Munoz-Negrete F
Invest Ophthalmol Vis Sci
. 2015 Jun;
56(4):2568-9.
PMID: 26066601
No abstract available.
8.
Tejerina E, Jimenez-Heffernan J, Ley L, Corbacho C, Sanz E
Acta Cytol
. 2010 Mar;
54(1):105-7.
PMID: 20307001
No abstract available.